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. The absence of the homozygous allele of the GSTM1 gene (GSTM1 null genotype) results in a complete loss of enzyme activity for binding with genotoxic substrates; including the epoxides derived from aflatoxin and PAHs, resulting in a decreased capacity to detoxify carcinogens (Hayes and Pulford, 1995, Sreelekha et al., 2001) . It is believed that individuals with the GSTM1 null genotype lack the functional ability to detoxify the ultimate form of carcinogens and are, therefore, susceptible to cancer in various organs (including the lung, bladder, oral and nasopharynx) (Schnakenberg et al., 2000; Shield PG., 2002; Tiwawech et al., 2005; Liu et al., 2014; Zakiullah et al., 2015) . Results of many other studies dealing with the association between GSTM1 polymorphism in some of these cancers have, however, proven contradictory (Tanimoto et al., 1999; Hahn et al., 2002; Natphopsuk et al., 2015) . Geographical and ethnic differences as well as the method of genotypic detection may be responsible for the apparently conflicting data. The real risk for all GSTM1 genotypes for oral cancer can be identified by distinguishing the homozygous wild-type from heterozygous individuals. In the current study, we investigated whether the GSTM1 genotype was associated with risk of oral cancer and evaluate the potential role of smoke in the susceptibility to oral cancer in Northeastern Thailand.
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Materials and Methods
Study population
Study subjects comprised 79 cases (31 men, 48 women) and 79 age-and sex-matched healthy controls ranging in age from 25 to 84 years. These subjects attended Khon Kaen General Hospital, Srinagarind (Khon Kaen University) Hospital, Khon Kaen Regional Hospital or Sappasitthiprasong Ubon Ratchathani Hospital, all in Northeast Thailand between July 2010 and April 2011. Cases were histologically-confirmed as oral squamous cell carcinoma (OSCC), while controls were selected from among general walk-in patients at the Out-Patient Department of the hospitals and who were diagnosed with non-cancer conditions. Informed consent and a thorough interview were taken before blood collection. We only interviewed patients who consented to participate in the study: we used a standardized questionnaire concerning their tobacco use. The life-time smoking consumption history included the smoking status (smoke or never), smoking duration (year) and amount of smoking used (pack-year) were collected. The multiplying of number of packs of cigarettes smoked per day by the number of years the person has smoked was estimated as a smoking pack-year (one pack contains 20 cigarettes). Our study was reviewed and approved by the Ethics Committee of Khon Kaen University (HE 521344).
Detection of GSTM1 polymorphism
Blood (3 ml) from each subject was collected in an EDTA tube and genomic DNAs were extracted by using the GF-1 Blood DNA Extraction Kit (Vivantis, USA).
GSTM1 genotype was determined by the two independent PCR assays described by Natphopsuk et al. (2015) . To identify the GSTM1 null allele, a short-PCR amplification (Tiwawech et al., 2005) was performed using a primer pairs (5'-GAA CTC CCT GAA AAG CTA AAG C-3' and 5'-GTT GGG CTC AAA TAT ACG GTG G-3'); an amplification of the β-globin was used as an internal control. PCR products were analyzed by 2.5% agarose gel electrophoresis. To identify the GSTM1 heterozygous allele, a long-PCR amplification was performed (Roodi et al., 2004 ) using a primer set of M3 (5'-CCT GTT GAA GGA GCT TAT GCT GAA-3') and M4 (5'-TTC TGA GGA CTG GAC TGA TGA TC-3') with KOD FX (Toyobo, Japan). The PCR product (14kb) was analyzed by 0.5% agarose gel electrophoresis.
Statistical analyses
The Chi-square test was used to compare genotypic frequencies between the case and control. The OR and 95%CI were calculated to determine the association between selected variables and the risk for OSSC between the GSTM1 genotypes in both cases and controls. Statistical analyses were conducted using the statistical software 800-STATA for PC. A P-value of < 0.05 was required for statistical significance.
Results
The respective overall frequency of the GSTM1 null genotype among the controls and cases was 64.6% and 54.4%, respectively. The genotype distribution was in Hardy-Weinberg equilibrium. The respective genotype 
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distribution between controls vs cases of homozygous present (+/+), heterozygous present (+/-) and the null (-/-) genotype was 8.9%, 26.6% and 64. 6% vs 7.6%, 38.0% and 54.4%. The distribution of the GSTM1 genotypes was not significantly different between the cases and controls (p>0.05), and thus the GSTM1 null allele was not having an increased risk of oral cancer vs the wild type (Table1).
When the focus was on the GSTM1 genotypes in nonsmoking females, neither the null genotype of GSTM1 nor the heterozygous genotype altered the risk for OSCC (p>0.05) ( 
Discussion
GSTM1 polymorphism is one of the most studied loci vis-à-vis the risk of oral cancer. Homozygous deletion results in functional loss of GSTM1 enzyme (Gronau et al., 2003) , which has been implicated in the genesis of several types of cancer (Schnakenberg et al., 2000; Tiwawech et al., 2005; Liu et al., 2014; Zakiullah et al., 2015) . However, in this well designed case-control study with age -and sex-matched controls, the GSTM1 null genotype or the genotype distribution was not significantly associated with an increased risk of OSCC among northeastern Thais. This result confirmed no risk of association with the GSTM1 null among Caucasians (Deakin et al., 1996; Jourenkova-Mironova et al.,1999; Hahn et al., 2002) and Japanese (Tanimoto et al., 1999) . As shown in a previous meta-analysis, which revealed no increased oral cancer risk among Chinese subjects carrying the GSTM1 null (OR=1.41, 95%CI: 0.72-2.77, p=0.31) in contrast to a significant association between the GSTM1 genotype and oral cancer among Indians (OR=1.59, 95%CI: 1.20-2.11, p=0.001) (Peng et al., 2014) , risk of oral cancer was not consistent with respect to the GSTM1 null. Inconsistency in the risk of GSTM1 null for oral cancer was extracted from many references showing for example, 1) the deletion of GSTM1 increased the risk for oral cancer (Sato et al., 2000; Drummond et al., 2004) , or 2) GSTM1 null gene polymorphism might result in an increased risk of oral cancer in Asians but not Caucasians (Zhao et al., 2014) . We thus emphasize that the GSTM1 null polymorphism may be important in the ethnic specific risk of oral cancer. Ethnic and regional differences accord with lifestyle, which may affect the outcome of some genetic variations of the GSTM1 polymorphism. The diversity of association between the GSTM1 null genotype and oral cancer may differ by geographical region and socio-economic status. These assumptions are supported by the latitudinal cline in the distribution of the GSTM1 null genotype that is supposed to be the result of gene-environment adaptations (Saitou and Ishida, 2015) .
Tobacco smoke is well documented as a crucial cause of various types of cancer (Sobue et al., 2002; Samanic et al., 2006; Petti, 2009; Loyha et al., 2012; Natphopsuk et al., 2015) . In this study, of the GSTM1 genotype, interaction with smoking habit was not associated with risk of the OSCC. A similar finding vis-à-vis the GSTM1 genotype had no influence on oral cancer in non-smokers and occasional smokers but resulted in a higher risk in frequent smokers in Spain (Varela-Lema et al., 2008) . While a meta-analysis, however, revealed an association between the GSTM1 null genotype and a higher risk of oral cancer among Asians but not Caucasians; GSTM1 polymorphism might modify the relation between smoking status and oral cancer risk (Zhang et al., 2011) . It implies that smoking is more detrimental to persons who carry the GSTM1 gene in homozygous or heterozygous status. Our results showed that those who had smoking habit for >10 or >35 years but not more than 40 years were at high risks (Table  3 ). This trend, much longer smoking history reduces the risk, was previously also reported; among those who have survived against much longer and/or larger exposure to smoking, the risk of smoking seems to be masked and other critical risk(s) than smoking may become tangible. We also found the higher risks of smoking pack-years for >5 and >10; this suggests that at high amounts and longer durations of smoking there is an accumulation of carcinogens, which overwhelm detoxification systems, leading to carcinogenesis. When the ORs were calculated only among smokers, none of the categories showed significant (data not shown). This indicates that the status of smoking or non-smoking is highly critical in the development of oral cancer. In conclusion, these findings suggest certain smoking patterns are at greater risk and to reduce the risk of smoking-related cancer, both smoking duration and pack-years should be addressed. 
